Lysaght et al., 1994 - Google Patents
Recent progress in immunoisolated cell therapyLysaght et al., 1994
- Document ID
- 8752365099941487994
- Author
- Lysaght M
- Frydel B
- Gentile F
- Emerich D
- Winn S
- Publication year
- Publication venue
- Journal of cellular biochemistry
External Links
Snippet
Biohybrid implalts represent a new class of medical device in which living cells, supported in a hydrogel matrix, and surrounded by semipepmiable membrane, produce and deliver therapeutic reagents tm specific sites wthin a host. First prpmsed in the mid‐1970s for …
- 238000002659 cell therapy 0 title description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lysaght et al. | Recent progress in immunoisolated cell therapy | |
Lanza et al. | Islet transplantation with immunoisolation | |
Lanza et al. | Transplantation of encapsulated cells and tissues | |
Sun et al. | Microencapsulation of living cells—a long-term delivery system | |
Lum et al. | Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets | |
Lee et al. | Cell transplantation for endocrine disorders | |
Lanza et al. | Encapsulated cell technology | |
Sun et al. | Microencapsulation of living cells and tissues | |
Kizilel et al. | The bioartificial pancreas: progress and challenges | |
US9540630B2 (en) | Optimization of alginate encapsulation of islets for transplantation | |
Lanza et al. | Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas | |
Lacy et al. | Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets | |
Colton | Implantable biohybrid artificial organs | |
AU666118B2 (en) | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products | |
AU725104B2 (en) | Retrievable bioartificial implants | |
Chaikof | Engineering and material considerations in islet cell transplantation | |
Zimmermann et al. | Hydrogel-based non-autologous cell and tissue therapy | |
Chang | Nonautologous somatic gene therapy | |
Zhu et al. | Treatment of diabetes with encapsulated pig islets: an update on current developments | |
Christenson et al. | Biomedical applications of immobilized cells | |
Krishnamurthy et al. | Encapsulated cell grafts to treat cellular deficiencies and dysfunction | |
Hou et al. | Biohybrid artificial pancreas based on macrocapsule device | |
Jaeger et al. | Polymer encapsulated dopaminergic cell lines as “alternative neural grafts” | |
Yang et al. | Calcium alginate | |
Sambanis | Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes |